{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidbxvlrgh37bgwqbbd3pesf45fixxx5xudgf6pzcy2cct5d5mzuby",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3ml7y3lg7aio2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/05/06/pharma-ad-campaign-aimed-at-340b-novo-obesity-pill-sales/?utm_campaign=rss",
  "publishedAt": "2026-05-06T13:34:07.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "Pharmalot",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "One of the most powerful pharmaceutical lobbying groups is launching a new seven-figure advertising blitz targeting a federal drug discount program",
  "title": "STAT+: Pharmalittle: We’re reading about a PhRMA ad campaign aimed at 340B, sales of Novo’s obesity pill, and more",
  "updatedAt": "2026-05-06T13:34:12.000Z"
}